MolDX: Lab-Developed Tests for Inherited Cancer Syndromes in Patients with Cancer
JE · Effective Aug 8, 2022
15 active Medicare policies list D02.4, and 1 commercial payer policy lists it. See each policy's status for the code and its official source. Listing a code is not a coverage decision: read each policy’s source for the requirements that apply.
Free account. Policy pages stay open to everyone.
JE · Effective Aug 8, 2022
JF · Effective Aug 8, 2022
JJ · Effective Jul 3, 2022
JM · Effective Jul 3, 2022
J5 · Effective Jul 3, 2022
J8 · Effective Jul 3, 2022
J9 · Effective Oct 1, 2015
JJ · Effective Jun 12, 2017
JM · Effective Jun 12, 2017
1 policy from 1 payer
Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
| Policy | Effective | Status of D02.4 |
|---|---|---|
| Low-Level Laser and High-Power Laser Therapy | Mar 15, 2026 | Covered |
National · Effective Jan 1, 2026
National · Effective Feb 5, 2026
J5 · Effective Jan 1, 2026
National · Effective Oct 30, 2025
National · Effective Oct 1, 2025
National · Effective Jan 1, 2026